ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Biotech firm Librede claims patent for cannabinoid fermentation

by Michael McCoy
April 26, 2019 | APPEARED IN VOLUME 97, ISSUE 17

 

09717-buscon14-cannabinolic.jpg

The California-based biotech firm Librede has been awarded a patent for its fermentation route to tetrahydrocannabinolic acid (THCA), which turns into tetrahydrocannabinol (THC) with heating or other methods. Librede says it already has patents on methods for making cannabidiol and cannabigerol. Fermentation of cannabinoids offers advantages over agricultural production, Librede says, including lower costs and carbon footprint.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment